Authors:
SCHULZ JB
WELLER M
MATTHEWS RT
HENEKA MT
GROSCURTH P
MARTINOU JC
LOMMATZSCH J
VONCOELLN R
WULLNER U
LOSCHMANN PA
BEAL MF
DICHGANS J
KLOCKGETHER T
Citation: Jb. Schulz et al., EXTENDED THERAPEUTIC WINDOW FOR CASPASE INHIBITION AND SYNERGY WITH MK-801 IN THE TREATMENT OF CEREBRAL HISTOTOXIC HYPOXIA, Cell death and differentiation, 5(10), 1998, pp. 847-857
Authors:
GLEICHMANN M
BEINROTH S
REED JC
KRAJEWSKI S
SCHULZ JB
WULLNER U
KLOCKGETHER T
WELLER M
Citation: M. Gleichmann et al., POTASSIUM DEPRIVATION-INDUCED APOPTOSIS OF CEREBELLAR GRANULE NEURONS- CYTOCHROME-C RELEASE IN THE ABSENCE OF ALTERED EXPRESSION OF BCL-2 FAMILY PROTEINS, Cellular physiology and biochemistry, 8(4), 1998, pp. 194-201
Authors:
SCHULZ JB
BEINROTH S
WELLER M
WULLNER U
KLOCKGETHER T
Citation: Jb. Schulz et al., ENDONUCLEOLYTIC DNA FRAGMENTATION IS NOT REQUIRED FOR APOPTOSIS OF CULTURED RAT CEREBELLAR GRANULE NEURONS, Neuroscience letters, 245(1), 1998, pp. 9-12
Authors:
WULLNER U
ISENMANN S
GLEICHMANN M
KLOCKGETHER T
BAHR M
Citation: U. Wullner et al., EXPRESSION OF NEUROTROPHINS AND NEUROTROPHIN RECEPTORS IN THE CEREBELLUM OF MUTANT WEAVER AND LURCHER MICE, Developmental brain research, 110(1), 1998, pp. 1-6
Authors:
HENEKA MT
LOSCHMANN PA
GLEICHMANN M
WELLER M
SCHULZ JB
WULLNER U
KLOCKGETHER T
Citation: Mt. Heneka et al., INDUCTION OF NITRIC-OXIDE SYNTHASE AND NITRIC OXIDE-MEDIATED APOPTOSIS IN NEURONAL PC12 CELLS AFTER STIMULATION WITH TUMOR-NECROSIS-FACTOR-ALPHA LIPOPOLYSACCHARIDE, Journal of neurochemistry, 71(1), 1998, pp. 88-94
Authors:
REBER U
WULLNER U
TREPEL M
BAUMGART J
SEYFRIED J
KLOCKGETHER T
DICHGANS J
WELLER M
Citation: U. Reber et al., POTENTIATION OF TREOSULFAN TOXICITY BY THE GLUTATHIONE-DEPLETING AGENT BUTHIONINE SULFOXIMINE IN HUMAN-MALIGNANT GLIOMA-CELLS - THE ROLE OFBCL-2, Biochemical pharmacology, 55(3), 1998, pp. 349-359
Authors:
WULLNER U
WELLER M
SCHULZ JB
KRAJEWSKI S
REED JC
KLOCKGETHER T
Citation: U. Wullner et al., BCL-2, BAX AND BCL-X EXPRESSION IN NEURONAL APOPTOSIS - A STUDY OF MUTANT WEAVER AND LURCHER MICE, Acta Neuropathologica, 96(3), 1998, pp. 233-238
Authors:
LOSCHMANN PA
WULLNER U
HENEKA MT
SCHULZ JB
KUNOW M
WACHTEL H
KLOCKGETHER T
Citation: Pa. Loschmann et al., DIFFERENTIAL INTERACTION OF COMPETITIVE NMDA AND AMPA ANTAGONISTS WITH SELECTIVE DOPAMINE D-1 AND D-2 AGONISTS IN A RAT MODEL OF PARKINSONS-DISEASE, Synapse, 26(4), 1997, pp. 381-391
Authors:
WULLNER U
WELLER M
GROSCURTH P
LOSCHMANN PA
SCHULZ JB
MULLER I
KLOCKGETHER T
Citation: U. Wullner et al., EVIDENCE FOR AN ACTIVE TYPE OF CELL-DEATH WITH ULTRASTRUCTURAL FEATURES DISTINCT FROM APOPTOSIS - THE EFFECTS OF 3-ACETYLPYRIDINE NEUROTOXICITY, Neuroscience, 81(3), 1997, pp. 721-734
Authors:
WELLER M
SCHULZ JB
WULLNER U
LOSCHMANN PA
KLOCKGETHER T
DICHGANS J
Citation: M. Weller et al., DEVELOPMENTAL AND GENETIC-REGULATION OF PROGRAMMED NEURONAL DEATH, Journal of neural transmission. Supplementum, (50), 1997, pp. 115-123
Authors:
SOLBACH M
GUNDISCH D
WULLNER U
STAHLSCHMIDT A
KOVAR KA
MACHULLA HJ
Citation: M. Solbach et al., [C-11]METHYL-1-(1,3-BENZODIOXOL-5-YL)-2-BUTANAMINE (MBDB) - SYNTHESIS, QUALITY-CONTROL AND BIODISTRIBUTION, Journal of radioanalytical and nuclear chemistry, 224(1-2), 1997, pp. 109-112
Authors:
DOHMEN BM
WULLNER U
BECKER G
SOLBACH M
GUNDISCH D
KOVAR KA
BARES R
MACHULLA HJ
Citation: Bm. Dohmen et al., SYNTHESIS AND BIODISTRIBUTION OF [C-11]METHYL-1-(1,3-BENZODIOXOL-5-YL)-2-BUTANAMINE (MBDB), The Journal of nuclear medicine, 38(5), 1997, pp. 770-770
Authors:
SCHULZ JB
BREMEN D
WELLER M
LOSCHMANN PA
WULLNER U
KLOCKGETHER T
Citation: Jb. Schulz et al., SEQUENTIAL REQUIREMENT OF ICE-LIKE PROTEASES AND REACTIVE OXYGEN SPECIES IN NEURONAL APOPTOSIS, Neurology, 48(3), 1997, pp. 68007-68007
Authors:
SCHULZ JB
BREMEN D
LOMMATZSCH J
TAKAYAMA S
REED JC
WULLNER U
KLOCKGETHER T
WELLER M
Citation: Jb. Schulz et al., BCL-2 AND BAG-1 EXPRESSION BLOCK THE ACTIVATION OF CASPASES AND THE GENERATION OF REACTIVE OXYGEN SPECIES IN NEURONAL APOPTOSIS, Journal of neurochemistry, 69, 1997, pp. 215-215
Authors:
SCHULZ JB
BREMEN D
REED JC
LOMMATZSCH J
TAKAYAMA S
WULLNER U
LOSCHMANN PA
KLOCKGETHER T
WELLER M
Citation: Jb. Schulz et al., COOPERATIVE INTERCEPTION OF NEURONAL APOPTOSIS BY BCL-2 AND BAG-1 EXPRESSION - PREVENTION OF CASPASE ACTIVATION AND REDUCED PRODUCTION OF REACTIVE OXYGEN SPECIES, Journal of neurochemistry, 69(5), 1997, pp. 2075-2086
Authors:
WULLNER U
STANDAERT DG
TESTA CM
PENNEY JB
YOUNG AB
Citation: U. Wullner et al., DIFFERENTIAL EXPRESSION OF KAINATE RECEPTORS IN THE BASAL GANGLIA OF THE DEVELOPING AND ADULT-RAT BRAIN, Brain research, 768(1-2), 1997, pp. 215-223
Authors:
WULLNER U
LOSCHMANN PA
SCHULZ JB
SCHMID A
DRINGEN R
EBLEN F
TURSKI L
KLOCKGETHER T
Citation: U. Wullner et al., GLUTATHIONE DEPLETION POTENTIATES MPTP AND MPP(+) TOXICITY IN NIGRAL DOPAMINERGIC NEURONES, NeuroReport, 7(4), 1996, pp. 921-923
Authors:
KLOCKGETHER T
WULLNER U
STEINBACH JP
PETERSEN V
TURSKI L
LOSCHMANN PA
Citation: T. Klockgether et al., EFFECTS OF THE ANTIPARKINSONIAN DRUG BUDIPINE ON CENTRAL NEUROTRANSMITTER SYSTEMS, European journal of pharmacology, 301(1-3), 1996, pp. 67-73
Authors:
EBLEN F
LOSCHMANN PA
WULLNER U
TURSKI L
KLOCKGETHER T
Citation: F. Eblen et al., EFFECTS OF 7-NITROINDAZOLE, N-G-NITRO-L-ARGININE, AND D-CPPENE ON HARMALINE-INDUCED POSTURAL TREMOR, N-METHYL-D-ASPARTATE-INDUCED SEIZURES,AND LISURIDE-INDUCED ROTATIONS IN RATS WITH NIGRAL 6-HYDROXYDOPAMINE LESIONS, European journal of pharmacology, 299(1-3), 1996, pp. 9-16
Authors:
KLOCKGETHER T
WULLNER U
EBLEN F
LOSCHMANN PA
Citation: T. Klockgether et al., ANTIPARKINSONIAN ACTION OF GLUTAMATE ANTAGONISTS - INTERACTION WITH DOPAMINE D1 AND D2 AGONISTS, Annals of neurology, 38(2), 1995, pp. 329-329
Authors:
LOSCHMANN PA
EBLEN F
WULLNER U
KLOCKGETHER T
Citation: Pa. Loschmann et al., NMDA-MEDIATED TOXICITY TO STRIATAL NEURONS IS NOT REVERSED BY 7-NITROINDAZOLE, AN INHIBITOR OF NEURONAL NITRIC-OXIDE SYNTHASE, Journal of neural transmission. Supplementum, (46), 1995, pp. 87-95
Authors:
LOSCHMANN PA
EBLEN F
WULLNER U
WACHTEL H
KLOCKGETHER T
Citation: Pa. Loschmann et al., LAMOTRIGINE HAS NO ANTIPARKINSONIAN ACTIVITY IN RAT MODELS OF PARKINSONS-DISEASE, European journal of pharmacology, 284(1-2), 1995, pp. 129-134